Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine.

JAAD Case Rep

Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Published: May 2023

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176165	PMC
http://dx.doi.org/10.1016/j.jdcr.2023.02.016	DOI Listing

Publication Analysis

anti-transcriptional intermediary

intermediary factor-1γ

factor-1γ antibody-positive

antibody-positive dermatomyositis

dermatomyositis patient

patient triple-negative

triple-negative breast

breast cancer

cancer treated

treated adjuvant

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!